tykhr
sign in
free sign up
NGM Biopharmaceuticals Inc
Biotechnology
Healthcare
NGM
82.46 M shares
NASDAQ US
traded
12 Sep 2023
listed
yes
open
1.55
52 week high
16.73
high
1.58
52 week low
1.51
low
1.50
growth
-88.01 %
previous Close
1.51
P/E ratio
market cap
180 M
div yield
0
usd
Jun 2023
qoq
revenue
1.42 M
-36.67 %
net incoming
-38.26 M
15.16 %
eps
0.00 %
20.69 %
eps surprise
8.00 %
net profit margin
-2688.76 %
-681.00 %
operating incoming
-40.58 M
19.16 %
net change in cash
-14.28 M
-141.71 %
cash on hand
53.27 M
-21.14 %
cost of revenue
0.00 %
top